CRISPR-Cas12a

Kevin Luk1, Pengpeng Liu1, Jing Zeng2,3,4

  • 1Department of Molecular, Cell and Cancer Biology, Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA.

GEN biotechnology
|February 26, 2024
PubMed
概括

研究人员优化了CRISPR-Cas12a (一种基因组编辑工具),以增强其在人类细胞中的活性. 这种改进的Cas12a系统在原始细胞中显示出强大的编辑能力,而不会增加非目标突变,为基因治疗提供了一个有前途的工具.